Literature DB >> 20448572

Fighting off pain with resolvins.

Claudia Sommer, Frank Birklein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448572     DOI: 10.1038/nm0510-518

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

Review 1.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

2.  A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.

Authors:  Robert J Goldberg; Joel Katz
Journal:  Pain       Date:  2007-03-01       Impact factor: 6.961

3.  The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons.

Authors:  R Nixon; N Bansback; A Brennan
Journal:  Rheumatology (Oxford)       Date:  2007-05-03       Impact factor: 7.580

Review 4.  Omega 3 and 6 oils for primary prevention of allergic disease: systematic review and meta-analysis.

Authors:  C Anandan; U Nurmatov; A Sheikh
Journal:  Allergy       Date:  2009-04-07       Impact factor: 13.146

Review 5.  Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).

Authors:  Frank Birklein; Martin Schmelz
Journal:  Neurosci Lett       Date:  2008-03-30       Impact factor: 3.046

Review 6.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Authors:  Charles N Serhan; Nan Chiang; Thomas E Van Dyke
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

7.  Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF.

Authors:  Bettina K Beyreuther; Christian Geis; Thomas Stöhr; Claudia Sommer
Journal:  Neuropharmacology       Date:  2007-02-04       Impact factor: 5.250

Review 8.  Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease.

Authors:  Dan Turner; Stanley H Zlotkin; Prakeshkumar S Shah; Anne Marie Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

9.  Efficacy and safety of lacosamide in painful diabetic neuropathy.

Authors:  Dan Ziegler; Tibor Hidvégi; Irina Gurieva; Sabine Bongardt; Rainer Freynhagen; David Sen; Kenneth Sommerville
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 19.112

Review 10.  Long-term opioid management for chronic noncancer pain.

Authors:  Meredith Noble; Jonathan R Treadwell; Stephen J Tregear; Vivian H Coates; Philip J Wiffen; Clarisse Akafomo; Karen M Schoelles
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more
  9 in total

1.  Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1.

Authors:  Chul-Kyu Park; Ning Lü; Zhen-Zhong Xu; Tong Liu; Charles N Serhan; Ru-Rong Ji
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 2.  Emerging roles of resolvins in the resolution of inflammation and pain.

Authors:  Ru-Rong Ji; Zhen-Zhong Xu; Gary Strichartz; Charles N Serhan
Journal:  Trends Neurosci       Date:  2011-09-30       Impact factor: 13.837

3.  Resolvins are potent analgesics for arthritic pain.

Authors:  Zhen-Zhong Xu; Ru-Rong Ji
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats.

Authors:  J F Lima-Garcia; R C Dutra; Kabs da Silva; E M Motta; M M Campos; J B Calixto
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

5.  Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1.

Authors:  Chul-Kyu Park; Zhen-Zhong Xu; Tong Liu; Ning Lü; Charles N Serhan; Ru-Rong Ji
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

6.  Microglial-neuronal interactions during neurodegenerative diseases.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2013-02-13       Impact factor: 4.147

Review 7.  Emerging targets in neuroinflammation-driven chronic pain.

Authors:  Ru-Rong Ji; Zhen-Zhong Xu; Yong-Jing Gao
Journal:  Nat Rev Drug Discov       Date:  2014-06-20       Impact factor: 84.694

8.  GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain.

Authors:  Sangsu Bang; Ya-Kai Xie; Zhi-Jun Zhang; Zilong Wang; Zhen-Zhong Xu; Ru-Rong Ji
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

9.  Body mass index and musculoskeletal pain: is there a connection?

Authors:  David R Seaman
Journal:  Chiropr Man Therap       Date:  2013-05-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.